Literature DB >> 18824536

Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Darin A Trier1, Kimberly D Gank, Deborah Kupferwasser, Nannette Y Yount, William J French, Alan D Michelson, Leon I Kupferwasser, Yan Q Xiong, Arnold S Bayer, Michael R Yeaman.   

Abstract

Platelets (PLTs) act in antimicrobial host defense by releasing PLT microbicidal proteins (PMPs) or PLT kinocidins (PKs). Receptors mediating staphylocidal efficacy and PMP or PK release versus isogenic PMP-susceptible (ISP479C) and -resistant (ISP479R) Staphylococcus aureus strains were examined in vitro. Isolated PLTs were incubated with ISP479C or ISP479R (PLT/S. aureus ratio range, 1:1 to 10,000:1) in the presence or absence of a panel of PLT inhibitors, including P2X and P2Y receptor antagonists of increasingly narrow specificity, and PLT adhesion receptors (CD41, CD42b, and CD62P). PLT-to-S. aureus exposure ratios of > or = 10:1 yielded significant reductions in the viability of both strains. Results from reversed-phase high-performance liquid chromatography indicated that staphylocidal PLT releasates contained PMPs and PKs. At ratios below 10:1, the PLT antistaphylococcal efficacy relative to the intrinsic S. aureus PMP-susceptible or -resistant phenotype diminished. Apyrase (an agent of ADP degradation), suramin (a general P2 receptor antagonist), pyridoxal 5'-phosphonucleotide derivative (a specific P2X(1) antagonist), and cangrelor (a specific P2Y(12) antagonist) mitigated the PLT staphylocidal response against both strains, correlating with reduced levels of PMP and PK release. Specific inhibition occurred in the presence and absence of homologous plasma. The antagonism of the thromboxane A(2), cyclooxygenase-1/cyclooxygenase-2, or phospholipase C pathway or the hindrance of surface adhesion receptors failed to impede PLT anti-S. aureus responses. These results suggest a multifactorial PLT anti-S. aureus response mechanism involving (i) a PLT-to-S. aureus ratio sufficient for activation; (ii) the ensuing degranulation of PMPs, PKs, ADP, and/or ATP; (iii) the activation of P2X(1)/P2Y(12) receptors on adjacent PLTs; and (iv) the recursive amplification of PMP and PK release from these PLTs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824536      PMCID: PMC2583569          DOI: 10.1128/IAI.00935-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  The role of platelets in antimicrobial host defense.

Authors:  M R Yeaman
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

Review 2.  Purinoceptor-evoked calcium signalling in human platelets.

Authors:  S O Sage; A B MacKenzie; S Jenner; M P Mahaut-Smith
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1997-10       Impact factor: 4.006

3.  Purification and in vitro activities of rabbit platelet microbicidal proteins.

Authors:  M R Yeaman; Y Q Tang; A J Shen; A S Bayer; M E Selsted
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus.

Authors:  V K Dhawan; M R Yeaman; A L Cheung; E Kim; P M Sullam; A S Bayer
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 5.  Role of cyclooxygenase-1 and -2 in health and disease.

Authors:  P E Lipsky
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1999-03

6.  Transposon disruption of the complex I NADH oxidoreductase gene (snoD) in Staphylococcus aureus is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1.

Authors:  Arnold S Bayer; Peter McNamara; Michael R Yeaman; Natalie Lucindo; Tiffanny Jones; Ambrose L Cheung; Hans-Georg Sahl; Richard A Proctor
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

7.  Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.

Authors:  J Jin; J L Daniel; S P Kunapuli
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

8.  Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.

Authors:  A S Bayer; P M Sullam; M Ramos; C Li; A L Cheung; M R Yeaman
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Roles of phospholipase C and Ca(2+)-ATPase in calcium responses of single, fibrinogen-bound platelets.

Authors:  J W Heemskerk; P Vis; M A Feijge; J Hoyland; W T Mason; S O Sage
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

10.  Effect of thrombocytopenia on the early course of streptococcal endocarditis.

Authors:  P M Sullam; U Frank; M R Yeaman; M G Täuber; A S Bayer; H F Chambers
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

View more
  20 in total

1.  In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.

Authors:  Nagendra N Mishra; James McKinnell; Michael R Yeaman; Aileen Rubio; Cynthia C Nast; Liang Chen; Barry N Kreiswirth; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

2.  Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro.

Authors:  Jessica M Gilbertie; Thomas P Schaer; Alicia G Schubert; Megan E Jacob; Stefano Menegatti; R Ashton Lavoie; Lauren V Schnabel
Journal:  J Orthop Res       Date:  2020-01-14       Impact factor: 3.494

Review 3.  Platelets: at the nexus of antimicrobial defence.

Authors:  Michael R Yeaman
Journal:  Nat Rev Microbiol       Date:  2014-06       Impact factor: 60.633

4.  Platelets Mediate Host Defense against Staphylococcus aureus through Direct Bactericidal Activity and by Enhancing Macrophage Activities.

Authors:  Ramadan A Ali; Leah M Wuescher; Keith R Dona; Randall G Worth
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

5.  Human platelets efficiently kill IgG-opsonized E. coli.

Authors:  Anum H Riaz; Brian E Tasma; Michael E Woodman; R Mark Wooten; Randall G Worth
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-20

6.  The efficacy of platelet-rich plasma gel in MRSA-related surgical wound infection treatment: an experimental study in an animal model.

Authors:  R A Cetinkaya; S Yilmaz; A Ünlü; P Petrone; C Marini; E Karabulut; M Urkan; E Kaya; K Karabacak; M Uyanik; I Eker; A Kilic; A Gunal
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-30       Impact factor: 3.693

Review 7.  Antiplatelet therapies for the treatment of cardiovascular disease.

Authors:  Alan D Michelson
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

8.  Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.

Authors:  Marie Crisel B Erfe; Consuelo V David; Cher Huang; Victoria Lu; Ana Claudia Maretti-Mira; Jacquelyn Haskell; Kevin W Bruhn; Michael R Yeaman; Noah Craft
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

Review 9.  Platelets: an outlook from biology through evidence-based achievements in critical care.

Authors:  Rubens C Costa-Filho; Fernando A Bozza
Journal:  Ann Transl Med       Date:  2017-11

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.